Alan Lotvin - Apr 1, 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Signature
/s/ Alan M. Lotvin
Stock symbol
CVS
Transactions as of
Apr 1, 2022
Transactions value $
$4,026,718
Form type
4
Date filed
4/5/2022, 07:28 PM
Previous filing
Feb 23, 2022
Next filing
Jul 13, 2022

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $7.88M +78K $101.09 78K Apr 1, 2022 Common Stock 78K $101.09 Direct F2
holding CVS Phantom Stock Credits 554 Apr 1, 2022 Common Stock 554 $1.00 Direct F3, F4
holding CVS Stock Option 27.4K Apr 1, 2022 Common Stock 27.4K $104.82 Direct F5
holding CVS Stock Option 32.9K Apr 1, 2022 Common Stock 32.9K $78.05 Direct F6
holding CVS Stock Option 22.5K Apr 1, 2022 Common Stock 22.5K $62.21 Direct F7
holding CVS Stock Option 70.7K Apr 1, 2022 Common Stock 70.7K $54.19 Direct F8
holding CVS Stock Option 141K Apr 1, 2022 Common Stock 141K $58.34 Direct F9, F10
holding CVS Stock Option 121K Apr 1, 2022 Common Stock 121K $74.30 Direct F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022.
F2 Option becomes exercisable in four equal installments, commencing 4/1/2023.
F3 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F4 Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F5 Option became exercisable in four equal annual installments, commencing 4/1/2017.
F6 Option became exercisable in four equal annual installments, commencing 4/3/2018.
F7 Option became exercisable in four equal annual installments, commencing 4/1/2019.
F8 Option became exercisable in four equal annual installments, commencing 4/1/2020.
F9 The number of shares subject to the option were calculated using a 30-day average price.
F10 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F11 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.